Zhejiang Tianyu Pharmaceutical Co., Ltd. (SHE:300702)
China · Delayed Price · Currency is CNY 22.68
+0.66 (3.00%)
Sep 30, 2026, 3:04 PM CST
SHE:300702 Financials Overview
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Revenue Revenue Growth | 3,296 | 3,061 | 2,631 | 2,527 | 2,667 | 2,545 |
Revenue Growth | 4.93% | 16.36% | 4.10% | -5.23% | 4.78% | -1.64% |
Gross Profit Gross Profit Growth | 1,067 | 1,065 | 869.86 | 849.83 | 591.07 | 907.42 |
Operating Income Operating Income Growth | 180.22 | 203.69 | 111.1 | 146.09 | -79.67 | 185.84 |
Net Income Net Income Growth | 90.54 | 139.71 | 55.94 | 27.36 | -118.87 | 204.68 |
Earnings Per Share EPS Growth | 0.27 | 0.41 | 0.16 | 0.08 | -0.34 | 0.59 |
EPS Growth | -40.83% | 156.25% | 100.00% | - | - | -71.22% |
| Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|
| Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Generic drug APIs and intermediates Generic drug APIs and intermediates Growth | 2,222 | 1,994 | 2,005 | 2,350 | 1,964 |
CDMO APIs and Intermediates CDMO APIs and Intermediates Growth | 391.9 | 365.8 | 405.66 | 263.08 | 557.24 |
Preparations Preparations Growth | 418 | 254.76 | 105.03 | 33.97 | 3.97 |
other other Growth | 29.36 | 16.13 | 11.84 | 19.62 | 19.88 |
Total Total Growth | 3,061 | 2,631 | 2,527 | 2,667 | 2,545 |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Cash & Investments Cash & Investments Growth | 634.69 | 513.05 | 592.87 | 426.15 | 476.98 | 549.7 |
Total Debt Total Debt Growth | 1,907 | 1,770 | 1,836 | 1,799 | 1,287 | 637.26 |
Net Cash (Debt) Net Cash Growth | -1,272 | -1,257 | -1,243 | -1,373 | -810.23 | -87.56 |
Net Cash Growth | - | - | - | - | - | - |
Net Cash Per Share Net Cash Per Share Growth | -3.74 | -3.69 | -3.56 | -4.01 | -2.32 | -0.25 |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Cash Flow Operating Cash Flow Growth | 898.14 | 473.57 | 344.64 | -43.9 | -48.7 | -262.23 |
Capital Expenditures CapEx Growth | -308.45 | -357.77 | -168.95 | -316.81 | -527.01 | -736.39 |
Free Cash Flow Free Cash Flow Growth | 589.69 | 115.8 | 175.69 | -360.71 | -575.71 | -998.62 |
Free Cash Flow Growth | - | -34.09% | - | - | - | - |
| Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Jun '26 Jun 30, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Gross Margin | 32.36% | 34.78% | 33.06% | 33.63% | 22.17% | 35.66% |
Operating Margin | 5.47% | 6.65% | 4.22% | 5.78% | -2.99% | 7.30% |
Pretax Margin | 3.30% | 5.18% | 2.99% | 2.85% | -4.14% | 8.58% |
Profit Margin | 2.75% | 4.56% | 2.13% | 1.08% | -4.46% | 8.04% |
FCF Margin | 17.89% | 3.78% | 6.68% | -14.27% | -21.59% | -39.24% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Dividend Per Share Dividend Per Share Growth | 0.050 | 0.050 | 0.050 | 0.050 | - | 0.100 |
Dividend Per Share Growth | 0% | 0% | 0% | - | - | -64.00% |
Dividend Yield | 0.22% | 0.21% | 0.30% | 0.23% | - | 0.21% |
| Fiscal Year | Current | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
| Period Ending | Oct '26 Oct 2, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
PE Ratio | 85.16 | 58.10 | 102.44 | 276.13 | - | 82.20 |
Forward PE | 24.92 | 25.79 | 34.35 | 33.57 | 51.04 | 17.99 |
P/FCF Ratio | 13.27 | 70.09 | 32.61 | - | - | - |
PS Ratio | 2.37 | 2.65 | 2.18 | 2.99 | 3.33 | 6.61 |